SPAG9
Basic information
Region (hg38): 17:50962174-51120868
Links
Phenotypes
GenCC
Source:
- schizophrenia (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPAG9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 67 | 69 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 68 | 3 | 6 |
Variants in SPAG9
This is a list of pathogenic ClinVar variants found in the SPAG9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-50966350-A-T | not specified | Uncertain significance (Jun 13, 2024) | ||
17-50966364-G-A | not specified | Uncertain significance (Nov 04, 2023) | ||
17-50970712-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
17-50970752-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
17-50970766-G-A | not specified | Uncertain significance (Dec 07, 2024) | ||
17-50970775-C-T | not specified | Uncertain significance (Dec 02, 2024) | ||
17-50970782-C-T | not specified | Uncertain significance (Dec 07, 2023) | ||
17-50970811-G-A | not specified | Uncertain significance (Oct 07, 2024) | ||
17-50970824-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
17-50970845-T-C | not specified | Uncertain significance (Dec 07, 2024) | ||
17-50974800-T-A | not specified | Uncertain significance (Nov 21, 2022) | ||
17-50974804-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
17-50974812-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
17-50974900-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
17-50974932-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
17-50977137-C-G | not specified | Uncertain significance (Sep 22, 2023) | ||
17-50979869-C-T | not specified | Uncertain significance (Nov 13, 2023) | ||
17-50982628-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
17-50982647-A-G | Benign (Dec 31, 2019) | |||
17-50984913-C-T | Benign (Dec 31, 2018) | |||
17-50984926-C-A | not specified | Uncertain significance (Jan 26, 2023) | ||
17-50984941-T-C | not specified | Uncertain significance (Feb 23, 2023) | ||
17-50985714-A-C | not specified | Uncertain significance (Jun 03, 2022) | ||
17-50987169-T-G | not specified | Uncertain significance (Nov 09, 2021) | ||
17-50989671-T-C | Likely benign (May 18, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPAG9 | protein_coding | protein_coding | ENST00000262013 | 30 | 158692 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 6.54e-9 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.13 | 479 | 715 | 0.670 | 0.0000370 | 8651 |
Missense in Polyphen | 102 | 217.98 | 0.46793 | 2449 | ||
Synonymous | 1.18 | 234 | 258 | 0.907 | 0.0000136 | 2507 |
Loss of Function | 7.43 | 5 | 74.0 | 0.0676 | 0.00000393 | 896 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000444 | 0.0000439 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000658 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Isoform 5 may play a role in spermatozoa-egg- interaction. {ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:15693750}.;
- Pathway
- EGF-Ncore;Developmental Biology;CDO in myogenesis;Myogenesis;Arf6 trafficking events;TNFalpha
(Consensus)
Recessive Scores
- pRec
- 0.200
Intolerance Scores
- loftool
- 0.399
- rvis_EVS
- -1.13
- rvis_percentile_EVS
- 6.56
Haploinsufficiency Scores
- pHI
- 0.259
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.636
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.979
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spag9
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); pigmentation phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- activation of JUN kinase activity;vesicle-mediated transport;positive regulation of cell migration;retrograde transport, endosome to Golgi;positive regulation of neuron differentiation;striated muscle cell differentiation;positive regulation of muscle cell differentiation;protein homooligomerization
- Cellular component
- acrosomal vesicle;cytoplasm;microtubule organizing center;cytosol;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- MAP-kinase scaffold activity;protein binding;JUN kinase binding;kinesin binding;receptor signaling complex scaffold activity